Trial intelligence / Profile preview

Juvista for Ear Lobe Keloids

NCT00836147Phase 2Completed

Sponsor
Renovo
Start
Feb 2009
Primary completion
Jun 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of avotermin in keloid, sponsored by Renovo. Started Feb 2009; status: completed.

02

Drugs

avotermin
03

Conditions

keloid

Beyond the preview

Go deeper on NCT00836147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00836147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call